Gilead Sciences

Director, Strategic Evidence and Collaborations, Medical Affairs

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Pharmaceuticals, HealthcareIndustries

Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)

Employment Type: Full-time

Position Overview

Gilead Sciences is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapeutics for areas of unmet medical need. Our mission is to advance the care of patients suffering from life-threatening diseases worldwide. We are seeking a Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC) to join our US Medical Affairs team. This role is remote, with quarterly travel to headquarters required.

Reporting to the Senior Director and Head of Strategic Evidence & Collaborations, US Medical Affairs (USMA), this position is responsible for co-developing the US Medical Affairs strategy for US Medical Affairs congress plans in collaboration with the COE (Congress Center of Excellence) and the USMA Strategy and Field Based Medical Teams.

The role involves representing and considering the US healthcare environment with internal and external stakeholders involved in cancer therapies, including both approved and pipeline molecules and indications. Key internal collaborators include:

  • Global Medical Affairs team
  • US Medical Access and Quality team
  • Scientific Communications/Publications
  • Medical Affairs Outcomes Research
  • Commercial Strategy
  • Marketing
  • Value and Market Access
  • Clinical Research/Development
  • US Public Affairs
  • US Government Affairs
  • Patient Engagement
  • Business Conduct (Legal)
  • Field-based US Medical Science Liaisons

Responsibilities

Specific responsibilities for this role include, but are not limited to:

  • Support US medical efforts in global and regional Congress strategic planning and tactical execution.
  • Lead the strategy for USMA for Global and Regional Congress Planning in collaboration with other cross-functional congress partners such as the Congress Center of Excellence, Global Medical Affairs, Field Medical, Regional Marketing, and other Commercial leads, as appropriate.
  • Lead and shepherd congress-related oncology Medical assets (e.g., booth) through the Medical Review Committee (MRC) process, in consultation with cross-functional Medical Affairs team members.
  • Lead the strategy and development of congress materials, including medical exhibit, sponsorship, and advertising investments.
  • Develop congress-specific content and manage it through the medical-legal-regulatory review process.
  • Serve as the specific point of contact for the Congress Center of Excellence (CoE), maintaining ongoing contact and visibility.
  • Collaborate with cross-functional partners to create a unified Medical Voice for congress strategy and execution.
  • Lead US efforts in collaboration with cross-functional colleagues.

About Gilead

At Gilead, we are creating a healthier world for all people. For over 35 years, we have tackled diseases such as HIV, viral hepatitis, COVID-19, and cancer, working relentlessly to develop therapies that improve lives and ensure global access. We continue to fight the world's biggest health challenges, and our mission requires collaboration, determination, and a relentless drive to make a difference. Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed, and empowered to fulfill their aspirations. Join Gilead and help create possible, together.

Headquarters: Foster City, California Operations: North America, Europe, Asia, and Australia.

For more information, please visit Gilead.com.

Skills

Medical Affairs
Oncology
Strategic Evidence
Collaborations
Biopharmaceutical
Therapeutics
Drug Development
Patient Care
Market Access

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI